These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

978 related articles for article (PubMed ID: 24925394)

  • 1. Bradykinin-mediated diseases.
    Kaplan AP
    Chem Immunol Allergy; 2014; 100():140-7. PubMed ID: 24925394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.
    Kaplan AP; Joseph K
    Clin Rev Allergy Immunol; 2016 Oct; 51(2):207-15. PubMed ID: 27273087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bradykinin-forming cascade and its role in hereditary angioedema.
    Kaplan AP; Joseph K
    Ann Allergy Asthma Immunol; 2010 Mar; 104(3):193-204. PubMed ID: 20377108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The plasma bradykinin-forming pathways and its interrelationships with complement.
    Kaplan AP; Ghebrehiwet B
    Mol Immunol; 2010 Aug; 47(13):2161-9. PubMed ID: 20580091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic pathways in the pathogenesis of hereditary angioedema: the role of C1 inhibitor therapy.
    Kaplan AP
    J Allergy Clin Immunol; 2010 Nov; 126(5):918-25. PubMed ID: 20889195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of hereditary angioedema.
    Zuraw BL; Christiansen SC
    Am J Rhinol Allergy; 2011; 25(6):373-8. PubMed ID: 22185738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma.
    Joseph K; Tuscano TB; Kaplan AP
    Ann Allergy Asthma Immunol; 2008 Sep; 101(3):279-86. PubMed ID: 18814451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
    Zeerleder S; Levi M
    Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
    Joseph K; Tholanikunnel TE; Kaplan AP
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of patients with angioedema without wheals: the importance of F12 gene screening.
    Firinu D; Bafunno V; Vecchione G; Barca MP; Manconi PE; Santacroce R; Margaglione M; Del Giacco SR
    Clin Immunol; 2015 Apr; 157(2):239-48. PubMed ID: 25744496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary angioedema in childhood: an approach to management.
    Ebo DG; Verweij MM; De Knop KJ; Hagendorens MM; Bridts CH; De Clerck LS; Stevens WJ
    Paediatr Drugs; 2010 Aug; 12(4):257-68. PubMed ID: 20593909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
    Kaplan AP
    Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novelties in the Diagnosis and Treatment of Angioedema.
    Cicardi M; Suffritti C; Perego F; Caccia S
    J Investig Allergol Clin Immunol; 2016; 26(4):212-21; quiz two pages after page 221. PubMed ID: 27470642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting.
    Craig TJ; Bernstein JA; Farkas H; Bouillet L; Boccon-Gibod I
    Int Arch Allergy Immunol; 2014; 165(2):119-27. PubMed ID: 25401373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE).
    Bork K
    Clin Rev Allergy Immunol; 2016 Oct; 51(2):183-92. PubMed ID: 27207174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of vascular permeability by antisense-mediated inhibition of plasma kallikrein and coagulation factor 12.
    Bhattacharjee G; Revenko AS; Crosby JR; May C; Gao D; Zhao C; Monia BP; MacLeod AR
    Nucleic Acid Ther; 2013 Jun; 23(3):175-87. PubMed ID: 23582057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bradykinin-mediated angioedema.
    Obtułowicz K
    Pol Arch Med Wewn; 2016; 126(1-2):76-85. PubMed ID: 26842379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of Hereditary Angioedema: The Role of the Bradykinin-Forming Cascade.
    Kaplan AP; Joseph K
    Immunol Allergy Clin North Am; 2017 Aug; 37(3):513-525. PubMed ID: 28687106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.